T-follicular helper (TFH) lymphoma is a blood cancer subgroup that continues to demonstrate a generally poor prognosis, with no standard treatment established to date. Although specific genetic ...

Novel combination of acimtamig and an allogenic natural killer cell product shows safety and promising objective response ...

Data presented at ASCO are the latest positive results for a subcutaneous version of this bispecific T-cell engager, which ...

Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative ...

During a live event, Gary J. Schiller, MD, explored the outcomes of the phase 1/2 trial of tagraxofusp-erzs in patients with ...

Glenmark, the world-renowned drug company, has revealed its intention to launch one of the rare drugs that can aid the ...

Mumbai: Glenmark Pharmaceuticals has announced the upcoming launch of the oral blood cancer treatment Zanubrutinib in India, ...

Is the long-awaited cure for cancer right around the corner? While the insidious disease continues to plague millions ...

Panelists discuss how the Inflation Reduction Act (IRA) might influence health care systems’ selection and utilization of Bruton tyrosine kinase (BTK) inhibitors, particularly through changes in ...

In addition to regularly saving lives threatened by emergencies, the Everett Fire Department also plays a role in the battle against blood cancers.

Applied Medical Technology, Inc. (AMT), a leader in innovative medical devices, is proud to announce the launch of its redesigned mobile application, AMT ONE Source®. This strategic update follows a ...

The NCPDP Foundation is pleased to announce the approval of a $200,000 grant to the CARIN Alliance for their innovative project aimed at enhancing consumer access to real-time pharmacy benefit ...